Showing 1 - 10 of 42
Persistent link: https://www.econbiz.de/10012004857
Persistent link: https://www.econbiz.de/10011947134
Persistent link: https://www.econbiz.de/10011998056
Persistent link: https://www.econbiz.de/10011869209
Persistent link: https://www.econbiz.de/10014514586
Objectives The UK's National Institute of Health and Clinical Excellence (NICE) has an explicit cost-effectiveness threshold for deciding whether or not services are to be provided in the National Health Service (NHS), but there is currently little evidence to support the level at which it is...
Persistent link: https://www.econbiz.de/10005077662
This paper critically reviews theoretical and empirical propositions regarding visual analogue scale (VAS) valuations of health states and their use in cost-utility analysis (CUA). A widely repeated assertion in the economic evaluation literature is the inferiority, on theoretical grounds, of...
Persistent link: https://www.econbiz.de/10005440519
The decisions made by the National Institute for Clinical Excellence (NICE) give rise to two questions: how is cost-effectiveness evidence used to make judgements about the 'value for money' of health technologies? And how are factors other than cost-effectiveness taken into account? The aim of...
Persistent link: https://www.econbiz.de/10005440585
Persistent link: https://www.econbiz.de/10005442759
Persistent link: https://www.econbiz.de/10005547406